General Information of Drug Off-Target (DOT) (ID: OTX254AR)

DOT Name Secreted phosphoprotein 24 (SPP2)
Synonyms Spp-24; Secreted phosphoprotein 2
Gene Name SPP2
Related Disease
Advanced cancer ( )
Colorectal carcinoma ( )
Cutaneous melanoma ( )
Dermatitis ( )
Endometrial cancer ( )
Endometrial carcinoma ( )
Melanoma ( )
Neoplasm ( )
Pancreatic cancer ( )
Hepatocellular carcinoma ( )
Retinitis pigmentosa ( )
UniProt ID
SPP24_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF07448
Sequence
MISRMEKMTMMMKILIMFALGMNYWSCSGFPVYDYDPSSLRDALSASVVKVNSQSLSPYL
FRAFRSSLKRVEVLDENNLVMNLEFSIRETTCRKDSGEDPATCAFQRDYYVSTAVCRSTV
KVSAQQVQGVHARCSWSSSTSESYSSEEMIFGDMLGSHKWRNNYLFGLISDESISEQFYD
RSLGIMRRVLPPGNRRYPNHRHRARINTDFE
Function Could coordinate an aspect of bone turnover.
Tissue Specificity Detected in liver and plasma.
Reactome Pathway
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) (R-HSA-381426 )
Post-translational protein phosphorylation (R-HSA-8957275 )
Platelet degranulation (R-HSA-114608 )

Molecular Interaction Atlas (MIA) of This DOT

11 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Biomarker [1]
Colorectal carcinoma DIS5PYL0 Strong Altered Expression [1]
Cutaneous melanoma DIS3MMH9 Strong Genetic Variation [1]
Dermatitis DISY5SZC Strong Altered Expression [2]
Endometrial cancer DISW0LMR Strong Genetic Variation [1]
Endometrial carcinoma DISXR5CY Strong Genetic Variation [1]
Melanoma DIS1RRCY Strong Genetic Variation [1]
Neoplasm DISZKGEW Strong Biomarker [3]
Pancreatic cancer DISJC981 Strong Altered Expression [1]
Hepatocellular carcinoma DIS0J828 Limited Biomarker [4]
Retinitis pigmentosa DISCGPY8 Limited Autosomal dominant [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Secreted phosphoprotein 24 (SPP2). [6]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Secreted phosphoprotein 24 (SPP2). [9]
------------------------------------------------------------------------------------
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Secreted phosphoprotein 24 (SPP2). [7]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Secreted phosphoprotein 24 (SPP2). [7]
Troglitazone DM3VFPD Approved Troglitazone decreases the expression of Secreted phosphoprotein 24 (SPP2). [8]
Rosiglitazone DMILWZR Approved Rosiglitazone decreases the expression of Secreted phosphoprotein 24 (SPP2). [8]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Secreted phosphoprotein 24 (SPP2). [10]
------------------------------------------------------------------------------------

References

1 Association between the expression of secreted phosphoprotein - related genes and prognosis of human cancer.BMC Cancer. 2019 Dec 18;19(1):1230. doi: 10.1186/s12885-019-6441-3.
2 Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses.Cell Signal. 2007 Apr;19(4):748-60. doi: 10.1016/j.cellsig.2006.09.004. Epub 2006 Sep 30.
3 Secreted phosphoprotein 24kD (Spp24) inhibits growth of hepatocellular carcinoma in vivo.Environ Toxicol Pharmacol. 2017 Apr;51:51-55. doi: 10.1016/j.etap.2017.03.001. Epub 2017 Mar 4.
4 Identification of special key genes for alcohol-related hepatocellular carcinoma through bioinformatic analysis.PeerJ. 2019 Feb 6;7:e6375. doi: 10.7717/peerj.6375. eCollection 2019.
5 SPP2 Mutations Cause Autosomal Dominant Retinitis Pigmentosa. Sci Rep. 2015 Oct 13;5:14867. doi: 10.1038/srep14867.
6 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
7 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
8 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
9 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
10 Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 1;89:42-49. doi: 10.1016/j.placenta.2019.10.008. Epub 2019 Oct 17.